CD73-IN-1
CD73-IN-1 is an inhibitor of CD73 which can be used in the treatment of cancer extracted from patent WO 2017153952 A1, example 80.
Product Specifications
CAS Number
2132396-40-6
UNSPSC
12352005
Target
CD73
Type
Reference compound
Related Pathways
Immunology/Inflammation
Applications
Cancer-programmed cell death
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/CD73-IN-1.html
Concentration
10mM
Purity
98.77
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(N)C1=CC(S(=O)(NC2=CC3=C(C=C2)C=C(C4CC4)N3)=O)=CC=C1O
Molecular Formula
C18H17N3O4S
Molecular Weight
371.41
References & Citations
[1]Jerry Leroy Adams, et al. 5-sulfamoyl-2-hydroxybenzamide derivatives. WO 2017153952 A1.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
TP306187M 100 µg
TXNDC (TMX1) (NM_030755) Human Recombinant Protein
Sign In for Pricing
View Details 
RD-ADORA2b-Hu-01 96 Tests
Human Adenosine A2b Receptor (ADORA2b) ELISA Kit
Sign In for Pricing
View Details RD-ADORA2b-Hu-02 48 Tests
Human Adenosine A2b Receptor (ADORA2b) ELISA Kit
Sign In for Pricing
View Details 